Grant C. Bogle Epizyme, Inc. (EPZM) insider trading activity

EPZM Quotes by TradingView

Grant C. Bogle is President and CEO of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 259,170 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Grant C. Bogle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
259,170 Reduced 100.0%
0 Common Stock, par valu...
Aug 09 2022
SELL
Payment of exercise price or tax liability
$1,597,946 $1.4 p/Share
1,141,390 Reduced 81.5%
259,170 Common Stock, par valu...
Aug 09 2022
BUY
Exercise of conversion of derivative security
$1,704,500 $1.4 p/Share
1,217,500 Added 65.05%
654,253 Common Stock, par valu...
Feb 02 2022
BUY
Grant, award, or other acquisition
-
87,500 Added 32.34%
183,060 Common Stock, par valu...
Aug 16 2021
BUY
Grant, award, or other acquisition
-
87,500 Added 47.8%
95,560 Common Stock, par valu...
Jun 11 2021
BUY
Grant, award, or other acquisition
-
8,060 Added 50.0%
8,060 Common Stock, par valu...

Also insider at

NUVL
Nuvalent, Inc. Healthcare
GCB

Grant C. Bogle

President and CEO
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EPZM